APAlexandre J. Parent

Alexandre J. Parent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandre J. Parent has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Nicolas Beaudet

    Univ. de Sherbrooke (Canada)

    4 shared publications
  • Philippe Sarret

    Department of Pharmacology and Physiology, Université de Sherbrooke, Administration, 2500 Boulevard de l'Université, Sherbrooke, Quebec J1K 2R1, Canada; Centre de recherche du CHUS, aile 9, porte 6, 3001 12e Avenue N, Sherbrooke, Quebec J1H 5N4, Canada

    4 shared publications
  • Alexandre Murza

    Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001, 12th Avenue North, Sherbrooke, J1H 5N4, QC, Canada

    2 shared publications
  • Philippe Goffaux

    Université de Sherbrooke, Sherbrooke, Québec

    2 shared publications
  • Philippe Sarret

    Université de Sherbrooke

    2 shared publications
  • Anaïs Lacasse

    Dép. des sciences de la santé, Université du Québec en Abitibi Témiscamingue, 445 Boulevard de l'Université, Rouyn-Noranda, Quebec J9X 5E4, Canada

    1 shared publication

Latest Publications

  • Preoperative Norepinephrine Levels in Cerebrospinal Fluid and Plasma Correlate With Pain Intensity After Pediatric Spine Surgery

    by Catherine E. Ferland, Alexandre J. Parent, Neil Saran, Pablo M. Ingelmo, Anaïs Lacasse, Serge Marchand, Philippe Sarret, Jean A. Ouellet

    Catecholamines were found to be involved in descending pain modulation and associated with perioperative pain. The purpose of the present study was to investigate the relationship between preoperative concentrations of catecholamines and postoperative pain intensity of pediatric patients. Fifty adolescents with idiopathic scoliosis scheduled for elective spinal fusion surgery were enrolled in this prospective cohort study. Preoperative plasma and cerebrospinal fluid (CSF) samples were collected and analyzed by mass spectrometry. Pain intensity was assessed during the acute postoperative period and in the intermediate period. Preoperative plasma concentrations of norepinephrine (NE) and normetanephrine (NME), as well as the CSF concentration of NE, were significantly correlated with the presence of pain six weeks after surgery (r = 0.48, 0.50, and 0.50, respectively; p < .002). We also found that preoperative NE levels in CSF were significantly higher in patients reporting moderate to severe pain intensity than in patients with mild pain during the first day following surgery (0.268 ± 0.29 ng/mL vs. 0.121 ± 0.074 ng/mL, p = .01), as well as between patients reporting pain and painless patients at 6 weeks postsurgery (0.274 ± 0.282 ng/mL vs. 0.103 ± 0.046 ng/mL respectively, U = 69.5, p = .002). These results support the potential role of catecholamine levels in predicting postoperative pain intensity.


  • Intracuff 160 mg alkalinized lidocaine reduces cough upon emergence from N2O-free general anesthesia: a randomized controlled trial

    by Houssine Souissi, Yannick Fréchette, Alexandre Murza, Marie-Hélène Masse, Éric Marsault, Philippe Sarret, Frédérick D’aragon, Alexandre J. Parent, Yanick Sansoucy

    Purpose Chemical and mechanical irritation of the tracheal mucosa influences the incidence of cough at emergence from general anesthesia, potentially leading to significant postoperative complications. This study evaluates the benefits of endotracheal tube (ETT) intracuff alkalinized lidocaine during N2O-free general anesthesia by 1) assessing the in vitro effect of alkalinization on lidocaine diffusion kinetics across the cuff’s membrane and 2) evaluating, in a randomized controlled clinical trial, the impact of 160 mg of intracuff alkalinized lidocaine on cough upon emergence from anesthesia for surgery lasting > 120 min. Methods In the in vitro study, diffusion kinetics of various intracuff alkalinized lidocaine amounts (40, 80, and 160 mg) were compared to their non-alkalinized lidocaine controls. In the clinical trial, 80 adult patients (American Society of Anesthesiologists physical status I-III) undergoing urological or gynecological surgery expected to last > 120 min and scheduled for N2O-free general anesthesia were enrolled. The ETT cuffs (high-volume, low-pressure) were filled with either 160 mg of alkalinized lidocaine or a comparable volume of 0.9% saline. The primary outcome was the incidence of cough upon emergence from anesthesia. Sore throat, hoarseness, and postoperative nausea and vomiting were evaluated as secondary outcomes. Results Our in vitro study confirmed that alkalinization increases lidocaine diffusion across the membrane of ETT cuffs and suggested that the lidocaine diffusion rate is associated with the initial intracuff lidocaine quantity. Our clinical trial demonstrated that, compared with the saline group, 160 mg of intracuff alkalinized lidocaine reduced the incidence of cough upon emergence from N2O-free general anesthesia (76% vs 34%, respectively; difference 42%; 95% confidence interval, 21% to 62%; P < 0.001) while having no clinical impact on secondary outcomes. Conclusions The use of 160 mg of intracuff alkalinized lidocaine is associated with a decreased incidence of cough upon emergence from N2O-free general anesthesia > 120 min. This trial was registered at www.clinicaltrials.gov (NCT01774292).


  • Descending nociceptive inhibition is modulated in a time-dependent manner in a double-hit model of chronic/tonic pain

    by A.J. Parent, P. Tétreault, M. Roux, K. Belleville, J.-M. Longpré, N. Beaudet, P. Goffaux, P. Sarret


  • Relationship Between Blood- and Cerebrospinal Fluid–Bound Neurotransmitter Concentrations and Conditioned Pain Modulation in Pain-Free and Chronic Pain Subjects

    by Alexandre J. Parent, Nicolas Beaudet, Kathya Daigle, Robert Sabbagh, Yanick Sansoucy, Serge Marchand, Philippe Sarret, Philippe Goffaux


  • Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain

    by Alexandre J. Parent, Nicolas Beaudet, Hélène Beaudry, Jenny Bergeron, Patrick Bérubé, Guy Drolet, Philippe Sarret, Louis Gendron


  • Elucidation of the Structure–Activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability

    by Alexandre Murza, Alexandre Parent, Elie Besserer‐Offroy, Hugo Tremblay, Félix Karadereye, Nicolas Beaudet, Richard Leduc, Philippe Sarret, Éric Marsault

    Apelin is the endogenous ligand of the APJ receptor, a member of the G‐protein‐coupled receptor family. The apelin–APJ complex has been detected in many tissues and is emerging as a promising target for several pathophysiological conditions. There is currently little information on the structure–activity relationship (SAR) of the apelin hormone. In an effort to better delineate SAR, we synthesized analogues of apelin‐13 modified at selected positions with unnatural amino acids, with a particular emphasis on the C‐terminal portion. Analogues were then tested in binding and functional assays by evaluating Gi/o‐mediated decreases in cAMP levels and by assessing β‐arrestin2 recruitment to the APJ receptor. The plasma stability of new compounds was also assessed. Several analogues were found to possess increased binding and higher stability than the parent peptide.